Discovery and Structural Optimization of 4-(Aminomethyl)benzamides as Potent Entry Inhibitors of Ebola and Marburg Virus Infections
- 16 June 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 63 (13), 7211-7225
- https://doi.org/10.1021/acs.jmedchem.0c00463
Abstract
The recent Ebola epidemics in West Africa underscore the great need for effective and practical therapies for future Ebola virus outbreaks. We have discovered a new series of remarkably potent small molecule inhibitors of Ebola virus entry. These 4-(aminomethyl)benzamide-based inhibitors are also effective against Marburg virus. Synthetic routes to these compounds allowed for the preparation of a wide variety of structures, including a conformationally restrained subset of indolines (compounds 41-50). Compounds 20, 23, 32, 33, and 35 are superior inhibitors of Ebola (Mayinga) and Marburg (Angola) infectious viruses. Representative compounds (20, 32, and 35) have shown good metabolic stability in plasma and liver microsomes (rat and human), and 32 did not inhibit CYP3A4 nor CYP2C9. These 4-(aminomethyl)benzamides are suitable for further optimization as inhibitors of filovirus entry, with the potential to be developed as therapeutic agents for the treatment and control of Ebola virus infections.Funding Information
- National Institute of Allergy and Infectious Diseases (R41 AI126971, R42 AI126971)
This publication has 46 references indexed in Scilit:
- Small molecule inhibitors reveal Niemann–Pick C1 is essential for Ebola virus infectionNature, 2011
- Identification of a Small-Molecule Entry Inhibitor for FilovirusesJournal of Virology, 2011
- Antiviral Activity of a Small-Molecule Inhibitor of Filovirus InfectionAntimicrobial Agents and Chemotherapy, 2010
- A broad-spectrum antiviral targeting entry of enveloped virusesProceedings of the National Academy of Sciences of the United States of America, 2010
- Zaire Ebola virus entry into human dendritic cells is insensitive to cathepsin L inhibitionCellular Microbiology, 2010
- Development of a broad-spectrum antiviral with activity against Ebola virusAntiviral Research, 2009
- Expression of Ebolavirus glycoprotein on the target cells enhances viral entryVirology Journal, 2009
- Structure of the Ebola virus glycoprotein bound to an antibody from a human survivorNature, 2008
- Comprehensive Analysis of Ebola Virus GP1 in Viral EntryJournal of Virology, 2005
- Marburg virus, a filovirus: méssenger RNAs, gene order, and regulatory elements of the replication cycleVirus Research, 1992